Transcription of Guideline on good pharmacovigilance practices (GVP)
{{id}} {{{paragraph}}}
9 October 2017. EMA/827661/2011 Rev 1*. Guideline on good pharmacovigilance practices (GVP). Module IX Signal management (Rev 1). Date of coming into effect of first version 2 July 2012. Draft Revision 1* finalised by the Agency in collaboration with Member 30 June 2016. States Draft Revision 1 agreed by the European Risk Management Facilitation 18 July 2016. Group (ERMS FG). Draft Revision 1 adopted by Executive Director 4 August 2016. Release for public consultation 8 August 2016. End of consultation (deadline for comments) 14 October 2016. Revised draft Revision 1 finalised by the Agency in collaboration with 27 September 2017. Member States Revised draft Revision 1 agreed by the EU Network pharmacovigilance 4 October 2017. Oversight Group (EU-POG). Revised draft Revision 1 adopted by Executive Director as final 9 October 2017. Date for coming into effect of Revision 1* 22 November 2017**.
Guideline on good pharmacovigilance practices (GVP) – Module IX (Rev 1) EMA/827661/2011 Rev 1 Page 2/25
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
GOOD DATA AND RECORD, Good data and record management practices, Data, Good, Practices, Guideline on good pharmacovigilance practices, Guideline on good pharmacovigilance practices GVP, Understanding of Good Manufacturing, Understanding of Good Manufacturing Practices Requirements and Execution, Certified Pharmaceutical Good Manufacturing, IPEC – PQG Good Manufacturing